Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00341640 · ClinicalTrials.gov registry record · Phase 1

Metabolism of Nicotine and Cotinine in Pregnant African-American Women

A Phase 1 study, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

Completed
Registry status
Phase 1
Development phase
50
Enrollment target

NCT00341640 is a Phase 1 study that has completed, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 50 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00341640, a Phase 1 study, has completed, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

COMPLETED
Registry status
Phase 1
Development phase
50 participants
Enrollment target

Study Summary

This study will provide information regarding the optimal dose and duration of nicotine replacement using the nicotine patch for a smoking cessation study of pregnant African-American women. Previous studies have shown that pregnancy, race and ethnicity can affect the way people metabolize nicotine. The information from this study may help scientists develop ways to help pregnant African-American women quit smoking and not start smoking again after delivery. African-American women 18-30years of age who are in the second trimester of a healthy pregnancy, who are carrying only one baby and who smoke 10 or more cigarettes a day may be eligible for this study. Candidates are screened with a medical history, physical examination and urine test. They receive counseling to help them quit smoking. Those who cannot quit smoking within 7 to 10 days after receiving counseling may be invited to join the study. Participants are admitted to a private room in the Pediatric Clinical Research Center at Children's National Medical Center in Washington, D.C., for 48 hours, during which time they are not permitted to smoke. After a "wash out" period, a nicotine patch will be applied according to these doses and schedules: * 21 mg patch for 24 hours * 21 mg patch for 16 hours * 14 mg patch for 24 hours * 14 mg patch for 16 hours An intravenous (IV) line is placed in the subject's arm and 12 blood samples are drawn through the line at intervals during the 48 hours. Twleve urine and saliva samples are also collected. Blood, urine, and saliva samples are analyzed for nicotine and cotinine (a product of nicotine metabolism) levels, and DNA will be collected studied for genes that are associated with nicotine and cotinine metabolism. Participants are interviewed about their urges to smoke, quality of sleep, etc.

Interventions

  • PROCEDURE Blood testing

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2005-01-06
Est. Completion 2006-12-01
Phase Phase 1

What the Registry Record Tells You About NCT00341640

The ClinicalTrials.gov registry entry for NCT00341640 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Blood testing is the first listed.

NCT00341640 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00341640 about?

NCT00341640 is a clinical study titled "Metabolism of Nicotine and Cotinine in Pregnant African-American Women". This study will provide information regarding the optimal dose and duration of nicotine replacement using the nicotine patch for a smoking cessation study of pregnant African-American women. Previous studies have shown that pregnancy, race and ethnicity can affect the way people metabolize nicotine....

What is the current status of trial NCT00341640?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2005-01-06. Estimated completion is 2006-12-01.

What interventions are being tested in trial NCT00341640?

The interventions under investigation include: Blood testing (PROCEDURE).

Who is sponsoring clinical trial NCT00341640?

This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.